Ahmed F. El-Yazbi
Research Subjects
Ahmed F. El-Yazbi has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Judith Nwaiwu
Department of Chemistry and Biochemistry
2 shared publicationsLabiba K. El-Khordagui
Department of Pharmaceutics, Faculty of Pharmacy
2 shared publicationsMostofa Al Amin Bhuiyan
Department of Chemistry and Biochemistry
2 shared publicationsNoha A. Hamdy
Department of Pharmacy Practice, Faculty of Pharmacy
2 shared publications- Yehia Mechref
Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, USA
2 shared publications Amr Y. El-Feky
Internal Medicine Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
1 shared publication
Latest Publications
- 5 February 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (3) , 1342-1355
LC-MS/MS-Profiling of Human Serum Unveils Significant Increase in Neuroinflammation and Carcinogenesis Following Chronic Organophosphate Exposure
The utilization of organophosphate pesticides (OPs) has escalated in response to the growing global food demand driven by a rapidly increasing population and the environmental disruptions caused by climate change. While acute exposure leads to cholinergic poisoning, chronic OP exposure has been linked to organ dysfunction, inflammation, and carcinogenesis. Serum samples from healthy individuals (n = 11), patients with acute OP exposure (n = 12), and those with chronic OP exposure (n = 31) were analyzed to discern the differentially expressed pathways after acute and chronic OP exposure. Differential expression analysis identified 132 proteins altered in chronic exposure vs control, 86 in acute exposure vs control, and 124 in chronic vs acute exposure. Pathway analysis revealed increased blood coagulation and reduced LXR/RXR activation and DCHR24 signaling in both acute and chronic exposures. Elevated levels of pro-inflammatory proteins, such as S100A8, VWF, and GPIBA, were observed, particularly in chronic exposure, highlighting significant inflammatory effects of OP exposure. These findings provide insights into the pathological mechanisms underlying chronic OP exposure and its contribution to inflammation and long-term health risks.
- 5 February 2025
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (3) , 1342-1355
LC-MS/MS-Profiling of Human Serum Unveils Significant Increase in Neuroinflammation and Carcinogenesis Following Chronic Organophosphate Exposure
The utilization of organophosphate pesticides (OPs) has escalated in response to the growing global food demand driven by a rapidly increasing population and the environmental disruptions caused by climate change. While acute exposure leads to cholinergic poisoning, chronic OP exposure has been linked to organ dysfunction, inflammation, and carcinogenesis. Serum samples from healthy individuals (n = 11), patients with acute OP exposure (n = 12), and those with chronic OP exposure (n = 31) were analyzed to discern the differentially expressed pathways after acute and chronic OP exposure. Differential expression analysis identified 132 proteins altered in chronic exposure vs control, 86 in acute exposure vs control, and 124 in chronic vs acute exposure. Pathway analysis revealed increased blood coagulation and reduced LXR/RXR activation and DCHR24 signaling in both acute and chronic exposures. Elevated levels of pro-inflammatory proteins, such as S100A8, VWF, and GPIBA, were observed, particularly in chronic exposure, highlighting significant inflammatory effects of OP exposure. These findings provide insights into the pathological mechanisms underlying chronic OP exposure and its contribution to inflammation and long-term health risks.
- Open Access
- 21 December 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 182, 117771
Positive impact of DPP-4 or SGLT2 inhibitors on mild cognitive impairment in type 2 diabetes patients on metformin therapy: A metabolomic mechanistic insight
- 21 December 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 182, 117771
Open AccessPositive impact of DPP-4 or SGLT2 inhibitors on mild cognitive impairment in type 2 diabetes patients on metformin therapy: A metabolomic mechanistic insight
- 8 August 2024
- Published by Springer Nature
- p. 97-118
Depot-Biased ROS: A Middleman in Adipose-Driven Cardiovascular Disease
- 8 August 2024
- Published by Springer Nature
- p. 97-118
Depot-Biased ROS: A Middleman in Adipose-Driven Cardiovascular Disease